ABX-CRO has more than 20 years of unique experience in the development of therapeutic radiopharmaceuticals and molecular imaging agents. Our experience from more than 50 phase 0-3 radiopharmaceutical studies including alpha, beta, auger, PET and SPECT radionuclides labeled with pharmacophores ranging from small molecules, peptides and monoclonals to medical devices is unmatched in the CRO industry.

Our specialized Image Core Lab for Molecular and Functional Imaging provides comprehensive solutions for all aspects of preclinical and clinical imaging and dosimetry. We provide solutions for radiolabeling, dosimetry, regulatory issues and the intricacies of functional imaging, which are often seen as major obstacles in the conduct of oncology and imaging studies.

• Scientific and strategic consulting
• Toxicology and preclinical pharmacology
• Regulatory and medical writing
• Clinical Operations Phase I-IV
• Data management and biostatistics
• Medical monitoring and pharmacovigilance
• Pharmacy and logistics